Copertina

Dysbiosis of the oral–gut microbiome in PCOS patients and its implication for noninvasive diagnosis

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Feiling Huang, Junru Chen, Miao Zhou, Ruiyi Tang, Shenglong Xu, Yan Zhao, Mingming Su, Xinlei Zhang, Peng Zhang, Rong Chen
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Clinical and Translational Medicine
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Dynamics of the intratumoural microbiome across malignant transformation and treatment in breast cancer
di: Liuliu Quan, et al.
Pubblicazione: (2025)

Faecal zonulin, calprotectin and the infant microbiome in early life
di: Mickayla Bacorn, et al.
Pubblicazione: (2024)

Targeting gut microbiota and metabolites in cancer radiotherapy
di: Shuling Ma, et al.
Pubblicazione: (2025)

Advancing prenatal diagnosis through comprehensive fetal cell‐free DNA screening
di: Qiong Luo, et al.
Pubblicazione: (2024)

MUC4 mutations promote a thrombotic phenotype in patients with paroxysmal nocturnal haemoglobinuria by increasing the deposition of terminal complement
di: Yingying Chen, et al.
Pubblicazione: (2026)

Single‐molecule epiallelic profiling of DNA derived from routinely collected Pap specimens for noninvasive detection of ovarian cancer
di: Christine M. O'Keefe, et al.
Pubblicazione: (2024)

Bridging the bench‐to‐bedside divide in microbiome research
di: Sondra Turjeman, et al.
Pubblicazione: (2025)

USP22 promotes the proliferation and Sorafenib resistance of hepatocellular carcinoma cells via its deubiquitinase activity
di: Xiaochen Wang, et al.
Pubblicazione: (2025)

A symbiotic mosquito‐gut bacterium for flavivirus control
di: Jinglin Wang, et al.
Pubblicazione: (2024)

Comprehensive pan‐cancer analysis of mitochondrial outer membrane permeabilisation activity reveals positive immunomodulation and assists in identifying potential therapeutic targets for immunotherapy resistance
di: Qingshan Chen, et al.
Pubblicazione: (2024)

Proteogenomic characterisation of primary oral cancer unveils extracellular matrix remodelling and immunosuppressive microenvironment linked to lymph node metastasis
di: Yu Liu, et al.
Pubblicazione: (2025)

Decoding MHC loss: Molecular mechanisms and implications for immune resistance in cancer
di: Pei Lin, et al.
Pubblicazione: (2025)

Circulating immune cell landscape and T‐cell abnormalities in patients with moyamoya disease
di: Peicong Ge, et al.
Pubblicazione: (2024)

Neuroimmune interactions: The bridge between inflammatory bowel disease and the gut microbiota
di: Jinxia Zhai, et al.
Pubblicazione: (2025)

Metabolic alterations of peripheral blood immune cells and heterogeneity of neutrophil in intracranial aneurysms patients
di: Xiaolong Ya, et al.
Pubblicazione: (2024)

Single‐cell analysis reveals cytotoxic and memory CD8 + T cells associated with prolonged survival in relapsed/refractory leukaemia patients after haplo+cord haematopoietic stem cell transplantation
di: Hua Li, et al.
Pubblicazione: (2026)

Alterations of the immune microenvironment with age predicts patient prognosis of gastrointestinal tract tumours
di: Fangzhen Li, et al.
Pubblicazione: (2026)

Revolutionising acute aortic syndrome diagnosis: The role of artificial intelligence in non‐contrast computed tomography
di: Qiqi Wang, et al.
Pubblicazione: (2026)

How generative AI reconfigure clinician–AI and clinician–patient relationships
di: Tianyi Shen, et al.
Pubblicazione: (2026)

Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy
di: Di Chen, et al.
Pubblicazione: (2024)

Single‐cell transcriptomics reveal metastatic CLDN4+ cancer cells underlying the recurrence of malignant pleural effusion in patients with advanced non‐small‐cell lung cancer
di: Xiaoshen Zhang, et al.
Pubblicazione: (2024)

Decoding endocrine cell differentiation: insights from high‐throughput CRISPR screening in human gut organoids
di: Lin Lin, et al.
Pubblicazione: (2024)

Immunometabolism: The role of gut‐derived microbial metabolites in optimising immune response during checkpoint inhibitor therapy
di: Agnieszka Beata Malczewski, et al.
Pubblicazione: (2025)

Evaluation of on‐ and off‐target effects of self‐assembled epidermal growth factor receptor small interfering RNA delivery system
di: Hongyuan Guo, et al.
Pubblicazione: (2024)

Pathologic nodal metastasis assessment using tumour‐derived molecular features in patients with lung adenocarcinoma
di: Shijie Wang, et al.
Pubblicazione: (2024)

N6‐methyladenosine‐modified circTEAD1 stabilizes Yap1 mRNA to promote chordoma tumorigenesis
di: Hanwen Li, et al.
Pubblicazione: (2024)

DNA methylation variability in pediatric aplastic anaemia contributes to T‐cell differentiation
di: Junchen Lai, et al.
Pubblicazione: (2026)

A new peptide inhibitor of C1QBP exhibits potent anti‐tumour activity against triple negative breast cancer by impairing mitochondrial function and suppressing homologous recombination repair
di: Xingxing Li, et al.
Pubblicazione: (2025)

Integrating multi‐omics features enables non‐invasive early diagnosis and treatment response prediction of diffuse large B‐cell lymphoma
di: Weilong Zhang, et al.
Pubblicazione: (2025)

HSP47 in human diseases: Navigating pathophysiology, diagnosis and therapy
di: Essak. S. Khan, et al.
Pubblicazione: (2024)

CD70: An emerging target for integrated cancer diagnosis and therapy
di: Jiatao Hu, et al.
Pubblicazione: (2025)

KMT2C/D mutations in newly diagnosed acute myeloid leukaemia: Clinical features, genetic co‐occurrences and prognostic significance
di: Wenting Wang, et al.
Pubblicazione: (2025)

Adipose tissue deficiency impairs transient lipid accumulation and delays liver regeneration following partial hepatectomy in male Seipin knockout mice
di: Qianqian Dong, et al.
Pubblicazione: (2025)

LRPPRC promotes glycolysis by stabilising LDHA mRNA and its knockdown plus glutamine inhibitor induces synthetic lethality via m6A modification in triple‐negative breast cancer
di: Yuanhang Yu, et al.
Pubblicazione: (2024)

Genotyping of RB1 status identifies two distinct subtypes in EGFR‐mutant lung cancers with SCLC transformation
di: Jie Huang, et al.
Pubblicazione: (2024)

Spectosis: One small step for NLRP3 but a giant leap for human mature red blood cells
di: Yaozhen Chen, et al.
Pubblicazione: (2025)

The gut microbiota‐derived metabolite indole‐3‐propionic acid enhances leptin sensitivity by targeting STAT3 against diet‐induced obesity
di: Zhiwei Wang, et al.
Pubblicazione: (2024)

Proteomic profiling of the serum of patients with COVID‐19 reveals key factors in the path to clinical improvement
di: Hye Seong, et al.
Pubblicazione: (2025)

The future of G protein‐coupled receptor therapeutics: Apelin receptor acts as a prototype for the advancement of precision drug design
di: Wei‐Wei Wang, et al.
Pubblicazione: (2024)

The multifaceted roles of the ACSL family in cancer: Metabolic reprogramming, ferroptosis regulation and tumour immune microenvironment remodelling
di: Haocai Li, et al.
Pubblicazione: (2026)